Evidence map›Paper›PMID 33234715›Full record

ArticleDevelopment (Cambridge, England)2021

Myung-Jun Kim, Michael B O'Connor

Open access · bronzeAbstract read
In one paragraph

Article in Development (Cambridge, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. International journal of molecular sciences · 2022
    Review
  12. microPublication biology · 2022
    Article
  13. Dysregulation of BMP, Wnt, and Insulin Signaling in Fragile X Syndrome.Frontiers in cell and developmental biology · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Myung-Jun KimDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA.
Michael B O'ConnorDepartment of Genetics, Cell Biology and Development, University of Minnesota, Minneapolis, MN 55455, USA moconnor@umn.edu.ORCID 0000-0002-3067-5506
University of Minnesota · US

Funding

Inter-organ signals regulating metabolism, physiology and developmental timingR35GM118029 · NIGMS · UNIVERSITY OF MINNESOTA · PI O'CONNOR, MICHAEL BRENDAN · 2016 to 2025
$3.8M
NIGMS NIH HHS R35 GM118029
6 · The paper itself

Abstract

The Myostatin/Activin branch of the TGF-β superfamily acts as a negative regulator of vertebrate skeletal muscle size, in part, through downregulation of insulin/insulin-like growth factor 1 (IGF-1) signaling. Surprisingly, recent studies in

Indexed as

Muscle DevelopmentSignal TransductionAnimalsDrosophila melanogasterDrosophila ProteinsFeedback, PhysiologicalGene Expression RegulationLarvaMechanistic Target of Rapamycin Complex 1Models, BiologicalMusclesMyosin Heavy ChainsPhosphorylationReceptor, InsulinRibosomal Protein S6 KinasesSarcomeresDrosophila ProteinsMechanistic Target of Rapamycin Complex 1Myosin Heavy ChainsReceptor, InsulinRibosomal Protein S6 KinasesTransforming Growth Factor betaActivinDrosophilaInsulinMuscle

Identifiers

PMID33234715
PMCPMC7823159
OpenAlexW3109259317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.